Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Dermatology (Basel, Switzerland)
|
November 1, 2014
To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index
Vito Ingordo, Simone Cazzaniga, Matelda Medri, et al.
Frontiers in Neuroscience
|
February 11, 2021
Retinal Vascular Assessment in Psoriasis: A Multicenter Study
Niccolò Castellino, Antonio Longo, Matteo Fallico, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
March 18, 2010
Quality of life and contact dermatitis: a disease-specific questionnaire
Fabio Ayala, Massimiliano Nino, Gabriella Fabbrocini, et al.
Contact Dermatitis
|
January 25, 2024
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study
Luca Stingeni, Caterina Foti, Fabrizio Guarneri, et al.
Psoriasis (Auckland, N.Z.)
|
July 4, 2025
Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience
Cristina Bertoli, Tiago Torres, Paolo Romita, et al.
The Journal of Dermatological Treatment
|
April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Stefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Contact Dermatitis
|
May 1, 2021
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019
Luca Stingeni, Rossella Marietti, Leonardo Bianchi, et al.
Clinical, Cosmetic and Investigational Dermatology
|
January 13, 2023
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
Luca Stingeni, Giovanna Malara, Andrea Conti, et al.
Clinical Drug Investigation
|
July 1, 2010
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation
Annalisa Arcese, Nicola Aste, Alberta Bettacchi, et al.
European Journal of Dermatology : EJD
|
March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Andrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Dermatology (Basel, Switzerland)
|
November 1, 2014
To what extent is quality of life impaired in vitiligo? A multicenter study on Italian patients using the dermatology life quality index
Vito Ingordo, Simone Cazzaniga, Matelda Medri, et al.
Frontiers in Neuroscience
|
February 11, 2021
Retinal Vascular Assessment in Psoriasis: A Multicenter Study
Niccolò Castellino, Antonio Longo, Matteo Fallico, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
March 18, 2010
Quality of life and contact dermatitis: a disease-specific questionnaire
Fabio Ayala, Massimiliano Nino, Gabriella Fabbrocini, et al.
Contact Dermatitis
|
January 25, 2024
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study
Luca Stingeni, Caterina Foti, Fabrizio Guarneri, et al.
Psoriasis (Auckland, N.Z.)
|
July 4, 2025
Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience
Cristina Bertoli, Tiago Torres, Paolo Romita, et al.
The Journal of Dermatological Treatment
|
April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Stefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Contact Dermatitis
|
May 1, 2021
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019
Luca Stingeni, Rossella Marietti, Leonardo Bianchi, et al.
Clinical, Cosmetic and Investigational Dermatology
|
January 13, 2023
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
Luca Stingeni, Giovanna Malara, Andrea Conti, et al.
Clinical Drug Investigation
|
July 1, 2010
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation
Annalisa Arcese, Nicola Aste, Alberta Bettacchi, et al.
European Journal of Dermatology : EJD
|
March 2, 2021
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Andrea Chiricozzi, Antonio Costanzo, Maria Concetta Fargnoli, et al.
Page
of 6